Industry: Food & Beverages
Published Date: 2026-02-11
Pages: 120 Pages
Report ld: 5979641
Request Sample
Customized Report
Engineered Bacterial Cell Protein Market Size(US$)

CAGR 2026-2032
12.3%
Market Size,2032
USD 322
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Engineered Bacterial Cell Protein market was valued at US$ 144 million in 2025 and is anticipated to reach US$ 322 million by 2032, at a CAGR of 12.3% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Engineered Bacterial Cell Protein competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
The North American market for Engineered Bacterial Cell Protein is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Engineered Bacterial Cell Protein is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Engineered Bacterial Cell Protein include Calysta, Shougang Lanza Tech, Air Protein (Kiverdi), ICell Sustainable Nutrition, String Bio, Unibio, Arbiom, NovoNutrients, Superbrewed Food, Solar Foods, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Engineered Bacterial Cell Protein market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Engineered Bacterial Cell Protein. The Engineered Bacterial Cell Protein market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Engineered Bacterial Cell Protein market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Engineered Bacterial Cell Protein manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Engineered Bacterial Cell Protein manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Engineered Bacterial Cell Protein sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Engineered Bacterial Cell Protein Market Overview
1.1 Product Definition
1.2 Engineered Bacterial Cell Protein by Type
1.2.1 Global Engineered Bacterial Cell Protein Market Value by Type: 2025 vs 2032
1.2.2 Industrial Waste as Raw Material
1.2.3 Transform Engineering bacteria as Raw Material
1.2.4 Others
1.3 Engineered Bacterial Cell Protein by Application
1.3.1 Global Engineered Bacterial Cell Protein Market Value by Application: 2025 vs 2032
1.3.2 Food
1.3.3 Feed
1.3.4 Others
1.4 Global Engineered Bacterial Cell Protein Market Size Estimates and Forecasts
1.4.1 Global Engineered Bacterial Cell Protein Revenue 2021–2032
1.4.2 Global Engineered Bacterial Cell Protein Sales 2021–2032
1.4.3 Global Engineered Bacterial Cell Protein Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Engineered Bacterial Cell Protein Market Competition by Manufacturers
2.1 Global Engineered Bacterial Cell Protein Sales Market Share by Manufacturers (2021–2026)
2.2 Global Engineered Bacterial Cell Protein Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Engineered Bacterial Cell Protein Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Engineered Bacterial Cell Protein, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Engineered Bacterial Cell Protein, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Engineered Bacterial Cell Protein, Product Types and Applications
2.7 Global Key Manufacturers of Engineered Bacterial Cell Protein, Date of Entry into the Industry
2.8 Global Engineered Bacterial Cell Protein Market Competitive Situation and Trends
2.8.1 Global Engineered Bacterial Cell Protein Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Engineered Bacterial Cell Protein Players Market Share by Revenue
2.8.3 Global Engineered Bacterial Cell Protein Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Engineered Bacterial Cell Protein Market Scenario by Region
3.1 Global Engineered Bacterial Cell Protein Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Engineered Bacterial Cell Protein Sales by Region: 2021–2032
3.2.1 Global Engineered Bacterial Cell Protein Sales by Region: 2021–2026
3.2.2 Global Engineered Bacterial Cell Protein Sales by Region: 2027–2032
3.3 Global Engineered Bacterial Cell Protein Revenue by Region: 2021–2032
3.3.1 Global Engineered Bacterial Cell Protein Revenue by Region: 2021–2026
3.3.2 Global Engineered Bacterial Cell Protein Revenue by Region: 2027–2032
3.4 North America Engineered Bacterial Cell Protein Market Facts & Figures by Country
3.4.1 North America Engineered Bacterial Cell Protein Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Engineered Bacterial Cell Protein Sales by Country (2021–2032)
3.4.3 North America Engineered Bacterial Cell Protein Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Engineered Bacterial Cell Protein Market Facts & Figures by Country
3.5.1 Europe Engineered Bacterial Cell Protein Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Engineered Bacterial Cell Protein Sales by Country (2021–2032)
3.5.3 Europe Engineered Bacterial Cell Protein Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Engineered Bacterial Cell Protein Market Facts & Figures by Region
3.6.1 Asia Pacific Engineered Bacterial Cell Protein Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Engineered Bacterial Cell Protein Sales by Region (2021–2032)
3.6.3 Asia Pacific Engineered Bacterial Cell Protein Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Engineered Bacterial Cell Protein Market Facts & Figures by Country
3.7.1 Latin America Engineered Bacterial Cell Protein Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Engineered Bacterial Cell Protein Sales by Country (2021–2032)
3.7.3 Latin America Engineered Bacterial Cell Protein Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Engineered Bacterial Cell Protein Market Facts & Figures by Country
3.8.1 Middle East and Africa Engineered Bacterial Cell Protein Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Engineered Bacterial Cell Protein Sales by Country (2021–2032)
3.8.3 Middle East and Africa Engineered Bacterial Cell Protein Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Engineered Bacterial Cell Protein Sales by Type (2021–2032)
4.1.1 Global Engineered Bacterial Cell Protein Sales by Type (2021–2026)
4.1.2 Global Engineered Bacterial Cell Protein Sales by Type (2027–2032)
4.1.3 Global Engineered Bacterial Cell Protein Sales Market Share by Type (2021–2032)
4.2 Global Engineered Bacterial Cell Protein Revenue by Type (2021–2032)
4.2.1 Global Engineered Bacterial Cell Protein Revenue by Type (2021–2026)
4.2.2 Global Engineered Bacterial Cell Protein Revenue by Type (2027–2032)
4.2.3 Global Engineered Bacterial Cell Protein Revenue Market Share by Type (2021–2032)
4.3 Global Engineered Bacterial Cell Protein Price by Type (2021–2032)
5 Segment by Application
5.1 Global Engineered Bacterial Cell Protein Sales by Application (2021–2032)
5.1.1 Global Engineered Bacterial Cell Protein Sales by Application (2021–2026)
5.1.2 Global Engineered Bacterial Cell Protein Sales by Application (2027–2032)
5.1.3 Global Engineered Bacterial Cell Protein Sales Market Share by Application (2021–2032)
5.2 Global Engineered Bacterial Cell Protein Revenue by Application (2021–2032)
5.2.1 Global Engineered Bacterial Cell Protein Revenue by Application (2021–2026)
5.2.2 Global Engineered Bacterial Cell Protein Revenue by Application (2027–2032)
5.2.3 Global Engineered Bacterial Cell Protein Revenue Market Share by Application (2021–2032)
5.3 Global Engineered Bacterial Cell Protein Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Calysta
6.1.1 Calysta Company Information
6.1.2 Calysta Description and Business Overview
6.1.3 Calysta Engineered Bacterial Cell Protein Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Calysta Engineered Bacterial Cell Protein Product Portfolio
6.1.5 Calysta Recent Developments/Updates
6.2 Shougang Lanza Tech
6.2.1 Shougang Lanza Tech Company Information
6.2.2 Shougang Lanza Tech Description and Business Overview
6.2.3 Shougang Lanza Tech Engineered Bacterial Cell Protein Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Shougang Lanza Tech Engineered Bacterial Cell Protein Product Portfolio
6.2.5 Shougang Lanza Tech Recent Developments/Updates
6.3 Air Protein (Kiverdi)
6.3.1 Air Protein (Kiverdi) Company Information
6.3.2 Air Protein (Kiverdi) Description and Business Overview
6.3.3 Air Protein (Kiverdi) Engineered Bacterial Cell Protein Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Air Protein (Kiverdi) Engineered Bacterial Cell Protein Product Portfolio
6.3.5 Air Protein (Kiverdi) Recent Developments/Updates
6.4 ICell Sustainable Nutrition
6.4.1 ICell Sustainable Nutrition Company Information
6.4.2 ICell Sustainable Nutrition Description and Business Overview
6.4.3 ICell Sustainable Nutrition Engineered Bacterial Cell Protein Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 ICell Sustainable Nutrition Engineered Bacterial Cell Protein Product Portfolio
6.4.5 ICell Sustainable Nutrition Recent Developments/Updates
6.5 String Bio
6.5.1 String Bio Company Information
6.5.2 String Bio Description and Business Overview
6.5.3 String Bio Engineered Bacterial Cell Protein Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 String Bio Engineered Bacterial Cell Protein Product Portfolio
6.5.5 String Bio Recent Developments/Updates
6.6 Unibio
6.6.1 Unibio Company Information
6.6.2 Unibio Description and Business Overview
6.6.3 Unibio Engineered Bacterial Cell Protein Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Unibio Engineered Bacterial Cell Protein Product Portfolio
6.6.5 Unibio Recent Developments/Updates
6.7 Arbiom
6.7.1 Arbiom Company Information
6.7.2 Arbiom Description and Business Overview
6.7.3 Arbiom Engineered Bacterial Cell Protein Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Arbiom Engineered Bacterial Cell Protein Product Portfolio
6.7.5 Arbiom Recent Developments/Updates
6.8 NovoNutrients
6.8.1 NovoNutrients Company Information
6.8.2 NovoNutrients Description and Business Overview
6.8.3 NovoNutrients Engineered Bacterial Cell Protein Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 NovoNutrients Engineered Bacterial Cell Protein Product Portfolio
6.8.5 NovoNutrients Recent Developments/Updates
6.9 Superbrewed Food
6.9.1 Superbrewed Food Company Information
6.9.2 Superbrewed Food Description and Business Overview
6.9.3 Superbrewed Food Engineered Bacterial Cell Protein Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Superbrewed Food Engineered Bacterial Cell Protein Product Portfolio
6.9.5 Superbrewed Food Recent Developments/Updates
6.10 Solar Foods
6.10.1 Solar Foods Company Information
6.10.2 Solar Foods Description and Business Overview
6.10.3 Solar Foods Engineered Bacterial Cell Protein Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Solar Foods Engineered Bacterial Cell Protein Product Portfolio
6.10.5 Solar Foods Recent Developments/Updates
6.11 Bond Pet Foods
6.11.1 Bond Pet Foods Company Information
6.11.2 Bond Pet Foods Description and Business Overview
6.11.3 Bond Pet Foods Engineered Bacterial Cell Protein Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Bond Pet Foods Engineered Bacterial Cell Protein Product Portfolio
6.11.5 Bond Pet Foods Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Engineered Bacterial Cell Protein Industry Chain Analysis
7.2 Engineered Bacterial Cell Protein Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Engineered Bacterial Cell Protein Production Mode & Process Analysis
7.4 Engineered Bacterial Cell Protein Sales and Marketing
7.4.1 Engineered Bacterial Cell Protein Sales Channels
7.4.2 Engineered Bacterial Cell Protein Distributors
7.5 Engineered Bacterial Cell Protein Customer Analysis
8 Engineered Bacterial Cell Protein Market Dynamics
8.1 Engineered Bacterial Cell Protein Industry Trends
8.2 Engineered Bacterial Cell Protein Market Drivers
8.3 Engineered Bacterial Cell Protein Market Challenges
8.4 Engineered Bacterial Cell Protein Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Engineered Bacterial Cell Protein was estimated to be worth US$ 144 million in 2025 and is projected to reach US$ 322 million, growing at a CAGR of 12.3% from 2026 to 2032.
Published Date: 2026-02-11
Pages: 113
USD 3950.00
(Single User License)
The global Engineered Bacterial Cell Protein market is projected to grow from US$ 130 million in 2024 to US$ 290 million by 2031, at a CAGR of 12.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-03
Pages: 160
USD 4900.00
(Single User License)
The global Engineered Bacterial Cell Protein market size was US$ 130 million in 2024 and is forecast to a readjusted size of US$ 290 million by 2031 with a CAGR of 12.3% during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 96
USD 4250.00
(Single User License)
The global market for Engineered Bacterial Cell Protein was estimated to be worth US$ 130 million in 2024 and is forecast to a readjusted size of US$ 290 million by 2031 with a CAGR of 12.3% during the forecast period 2025-2031.
Published Date: 2025-03-03
Pages: 129
USD 3950.00
(Single User License)
The global market for Engineered Bacterial Cell Protein was valued at US$ 130 million in the year 2024 and is projected to reach a revised size of US$ 290 million by 2031, growing at a CAGR of 12.3% during the forecast period.
Published Date: 2025-03-03
Pages: 89
USD 2900.00
(Single User License)
The global Engineered Bacterial Cell Protein market is projected to grow from US$ 117 million in 2024 to US$ 234.7 million by 2030, at a Compound Annual Growth Rate (CAGR) of 12.3% during the forecast period.
Published Date: 2024-04-14
Pages: 109
USD 4900.00
(Single User License)
The global Engineered Bacterial Cell Protein market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 234.7 million by 2030, witnessing a CAGR of 12.3% during the forecast period 2024-2030.
Published Date: 2024-01-18
Pages: 87
USD 2900.00
(Single User License)
The global market for Engineered Bacterial Cell Protein was estimated to be worth US$ 144 million in 2025 and is projected to reach US$ 322 million, growing at a CAGR of 12.3% from 2026 to 2032.
Published: 2026-02-11
Pages: 113
The global Engineered Bacterial Cell Protein market is projected to grow from US$ 130 million in 2024 to US$ 290 million by 2031, at a CAGR of 12.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-03
Pages: 160
The global Engineered Bacterial Cell Protein market size was US$ 130 million in 2024 and is forecast to a readjusted size of US$ 290 million by 2031 with a CAGR of 12.3% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 96
The global market for Engineered Bacterial Cell Protein was estimated to be worth US$ 130 million in 2024 and is forecast to a readjusted size of US$ 290 million by 2031 with a CAGR of 12.3% during the forecast period 2025-2031.
Published: 2025-03-03
Pages: 129
The global market for Engineered Bacterial Cell Protein was valued at US$ 130 million in the year 2024 and is projected to reach a revised size of US$ 290 million by 2031, growing at a CAGR of 12.3% during the forecast period.
Published: 2025-03-03
Pages: 89
The global Engineered Bacterial Cell Protein market is projected to grow from US$ 117 million in 2024 to US$ 234.7 million by 2030, at a Compound Annual Growth Rate (CAGR) of 12.3% during the forecast period.
Published: 2024-04-14
Pages: 109
The global Engineered Bacterial Cell Protein market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 234.7 million by 2030, witnessing a CAGR of 12.3% during the forecast period 2024-2030.
Published: 2024-01-18
Pages: 87
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now